Clinical Trials on Lungkarcinom, icke-småcelliga in Japan
Totalt 685 resultat
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupAktiv, inte rekryterandeIcke-skivepitel Icke-småcellig lungcancer | Cancer, lungaJapan
-
Tomoshi TsuchiyaAvslutad
-
Hamamatsu UniversityAvslutadIcke-småcellig lungcancerJapan
-
Kyowa Kirin Co., Ltd.Avslutad
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... och andra samarbetspartnersOkändIcke-småcellig lungcancerJapan
-
Shiga UniversityTokyo UniversityAvslutadIcke-småcellig lungcancerJapan
-
Shiga UniversityTokyo UniversityAvslutadIcke-småcellig lungcancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoOkändIcke småcellig lungcancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAvslutadIcke-småcellig lungcancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoOkändIcke småcellig lungcancerJapan
-
Shiga UniversityAvslutadIcke-småcellig lungcancerJapan
-
Kyowa Kirin Co., Ltd.AvslutadIcke-småcellig lungcancerJapan
-
TakedaRekryteringIcke-småcellig lungcancer (NSCLC)Japan
-
Novartis PharmaceuticalsAvslutad
-
Kanazawa UniversityOkändIcke-småcelligt lungkarcinomJapan
-
Bristol-Myers SquibbAvslutad
-
Kobe City General HospitalAvslutadAvancerad icke-småcellig lungcancerJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAvslutad
-
Kyowa Kirin Co., Ltd.AvslutadAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
R-PharmAvslutadIcke-småcellig lungcancer (NSCLC)Japan
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLCRekryteringIcke-småcellig lungcancer stadium II | Icke-småcellig lungcancer Stadium IB | Icke-småcellig lungcancerstadium ⅢAJapan
-
Kyowa Kirin Co., Ltd.Avslutad
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAvslutadIcke småcellig lungcancerJapan
-
Eisai Co., Ltd.AvslutadIcke-småcellig lungcancerJapan
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanOkänd
-
Astellas Pharma Global Development, Inc.Avslutad
-
Hamamatsu UniversityAvslutadIcke-småcellig lungcancerJapan
-
Genzyme, a Sanofi CompanyAvslutad
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoAvslutadIcke-småcellig lungcancerJapan
-
Bristol-Myers SquibbAvslutadIcke-småcellig lungcancerJapan
-
Daiichi Sankyo Co., Ltd.Avslutad
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdAvslutad
-
Eli Lilly and CompanyAvslutad
-
Gunma UniversityJ~pharmaAvslutadIcke-småcellig lungcancer | AngiogenesJapan
-
Eli Lilly and CompanyAvslutadIcke småcellig lungcancerJapan
-
Merck Sharp & Dohme LLCAvslutad
-
Bristol-Myers SquibbOno Pharma USA IncAvslutad
-
Juntendo UniversityMerck Sharp & Dohme LLCAktiv, inte rekryterandeIcke-skivepitel Icke-småcellig lungcancer | EGFR-aktiverande mutationJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanAvslutadIcke-småcelligt lungkarcinomJapan
-
Novartis PharmaceuticalsAvslutadIcke-småcellig lungcancerJapan
-
Eli Lilly and CompanyAvslutadSkivepitelcancer, icke-småcellig lungcancerJapan
-
Eli Lilly and CompanyAvslutadIcke-småcellig lungcancer MetastaserandeJapan
-
SandozNovartis PharmaceuticalsAvslutadIndolent B-cells non-Hodgkins lymfomJapan
-
PfizerAvslutadALK-positiv icke-småcellig lungcancerJapan
-
Merck Sharp & Dohme LLCAktiv, inte rekryterande
-
Astellas Pharma IncAvslutadIcke-småcellig lungcancerJapan, Korea, Republiken av, Taiwan
-
AstraZenecaAvslutadKarcinom, icke-småcellig lungaJapan